Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Decitabine plus CHOP vs CHOP in Previously Untreated PTCL
NCT03553537Phase 3Unknown
- Sponsor
- Southwest Health System
- Start
- Jun 2018
- Primary completion
- Jul 2021
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of decitabine in peripheral T-cell lymphoma (PTCL), sponsored by Southwest Health System. Status: unknown.
02
Drugs
decitabine
03
Conditions
peripheral T-cell lymphoma (PTCL)
Beyond the preview
Go deeper on NCT03553537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03553537.